Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Daneng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5330-7522; OpenAlex author ID A5037942451. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and … Co-author DOI 10.1016/j.jgo.2023.101474↗
  2. Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade. Co-author DOI 10.1186/s40169-018-0210-9↗
  3. Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer. Co-author DOI 10.1016/j.soc.2015.11.010↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter James O'Dwyer · 1 shared paper, 2023 · strength 0.16
  2. Efrat Dotan · 1 shared paper, 2023 · strength 0.16
  3. David Bing Zhen · 1 shared paper, 2023 · strength 0.16
  4. Eileen Mary O'Reilly · 1 shared paper, 2016 · strength 0.12
  5. Andrew Eugene Hendifar · 1 shared paper, 2018 · strength 0.09
  6. May Thet Cho · 1 shared paper, 2018 · strength 0.09
  7. Richard Tuli · 1 shared paper, 2018 · strength 0.09
  8. Jun Gong · 1 shared paper, 2018 · strength 0.09
  9. Vincent M. Chung · 1 shared paper, 2018 · strength 0.09
  10. Ravi Salgia · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.